|
KCTD21 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.98349999758207E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.3783000000499E-06 |
| Normal-vs-Stage2 |
1.76339999999886E-05 |
| Normal-vs-Stage3 |
5.12819997577907E-09 |
| Normal-vs-Stage4 |
5.408200E-04 |
| Stage1-vs-Stage2 |
1.133810E-01 |
| Stage1-vs-Stage3 |
5.036800E-03 |
| Stage1-vs-Stage4 |
6.705000E-01 |
| Stage2-vs-Stage3 |
7.134800E-01 |
| Stage2-vs-Stage4 |
4.324400E-01 |
| Stage3-vs-Stage4 |
1.713360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.46019999927682E-08 |
| Normal-vs-AfricanAmerican |
2.03959999999226E-05 |
| Normal-vs-Asian |
5.515600E-01 |
| Caucasian-vs-AfricanAmerican |
2.623200E-01 |
| Caucasian-vs-Asian |
1.882200E-01 |
| AfricanAmerican-vs-Asian |
1.537390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.16419984763638E-10 |
| Normal-vs-Female |
6.025600E-04 |
| Male-vs-Female |
2.363100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.361900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.11700000002568E-06 |
| Normal-vs-Age(61-80Yrs) |
1.99920002774689E-09 |
| Normal-vs-Age(81-100Yrs) |
4.426500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.314000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.714800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.936000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.404400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.267200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.742200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.097200E-01 |
| Normal-vs-Grade 2 |
9.76749999992421E-07 |
| Normal-vs-Grade 3 |
5.24340004748325E-09 |
| Normal-vs-Grade 4 |
2.163200E-04 |
| Grade 1-vs-Grade 2 |
2.213000E-01 |
| Grade 1-vs-Grade 3 |
7.933800E-02 |
| Grade 1-vs-Grade 4 |
2.864600E-01 |
| Grade 2-vs-Grade 3 |
1.394590E-01 |
| Grade 2-vs-Grade 4 |
9.787200E-01 |
| Grade 3-vs-Grade 4 |
3.111000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.07669999999771E-05 |
| Normal-vs-ccB subtype |
3.68089999591703E-08 |
| ccA subtype-vs-ccB subtype |
7.708000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.04270000411688E-08 |
| Normal-vs-N1 |
7.410300E-02 |
| N0-vs-N1 |
3.908600E-01 |
|
|
